Apollo Medical Holdings, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Mezzanine and Stockholders’ Equity (Tables)

Mezzanine and Stockholders’ Equity (Tables)

3 Months Ended

Mar. 31, 2018

The Company’s outstanding warrants consisted of the following:

	Shares		Weighted Average Exercise Price		Weighted Average Remaining Contractual Term (Years)		Aggregate Intrinsic Value

Warrants outstanding at January 1, 2017		3,648,541	$	9.75		3.74	$	14.25
Warrants granted		-		-		-		-
Warrants exercised		(191,625)		7.55		-		9.96
Warrants expired/forfeited		(11,250)		-		-		-

Warrants outstanding at March 31, 2018		3,445,666	$	9.88		3.69	$	6.07

								Weighted
				Weighted				Average
				Average				Exercise Price
Exercise Price Per		Warrants		Remaining		Warrants		Per
Share		Outstanding		Contractual Life		Exercisable		Share

$	4.50		24,000		0.60		24,000	$	4.50
	9.00		1,116,111		2.53		1,116,111		9.00
	10.00		1,455,555		4.05		1,455,555		10.00
	11.00		850,000		4.69		850,000		11.00

$	4.50 11.00		3,445,666		3.69		3,445,666	$	9.88

Contracted physicians and other services [Member]

Stock Option Transactions Under Stock Option Plans

Share-based compensation expense related to option awards granted to primary care physicians to purchase shares of APC’s common stock, recognized over their respective vesting periods, consisted of the following:

Three Months Ended March 31,	2018		2017

Contracted physicians and other services	$	202,382	$	321,233

Exclusivity Amendment Agreement, APC [Member]

Stock Option Transactions Under Stock Option Plans

Outstanding stock options granted to primary care physicians to purchase shares of APC’s common stock consisted of the following:

	Shares		Weighted Average Exercise Price		Weighted Average Remaining Contractual Term (Years)		Aggregate Intrinsic Value

Options outstanding at January 1, 2018		853,800	$	0.167		1.75	$	508,864
Options granted		-		-		-		-
Options exercised		-		-		-		-
Options expired/forfeited		-		-		-		-

Options outstanding at March 31, 2018		853,800	$	0.167		1.50	$	508,864

Options exercisable at March 31, 2018		853,800	$	0.167		1.50	$	508,864

Employee Stock Option [Member]

Stock Option Transactions Under Stock Option Plans

The Company’s outstanding stock options consisted of the following:

	Shares		Weighted Average Exercise Price		Weighted Average Remaining Contractual Term (Years)		Aggregate Intrinsic Value

Options outstanding at January 1, 2018		1,141,040	$	3.95		5.79	$	19.81
Options granted		30,000		9.25		-		-
Options exercised		(129,536)		6.11		-		15.03
Options forfeited		-		-		-		-

Options outstanding at March 31, 2018		1,041,504	$	4.09		5.66	$	11.86

Options exercisable at March 31, 2018		1,041,504	$	4.09		5.66	$	11.86

- Definition

Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.

+ References + Details